Polyclonal Antibody to Hyaluronic Acid (HA) Pan-species (General) Polyclonal antibody

Hyaluronan; Hyaluronate

Add to Cart Distributors
  • SourcePolyclonal antibody preparation, Host Rabbit
  • Ig Type IgG, Potency n/a
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelNone
  • Immunogen CPA182Ge21-OVA Conjugated Hyaluronic Acid (HA)
  • Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
  • TraitsLiquid, Concentration 500µg/mL
Share your citation Upload your experimental result Review Leave a message

Share a new citation as an author

Upload your experimental result


Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

E-mail address*
Verification code* CheckCode
  • Polyclonal Antibody to Hyaluronic Acid (HA) Packages (Simulation)
  • Polyclonal Antibody to Hyaluronic Acid (HA) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered


The antibody is a rabbit polyclonal antibody raised against HA. It has been selected for its ability to recognize HA in immunohistochemical staining and western blotting.


Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.


Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.


The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Organism Species More: Pan-species (General)


  • Hemorrhagic Fever Caused by a Novel Bunyavirus in China: Pathogenesis and Correlates of Fatal OutcomeOxfordJournals: source
  • Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: Role of platelet-derived growth factor pathway*PubMed: 22713216
  • Age effects on extracellular matrix production of vocal fold scar fibroblasts in ratsPubmed: 24077847
  • Vocal Fold Fibroblast Response to Growth Factor Treatment is Age Dependent: Results From an In Vitro StudyScienceDirect: S0892199713002415
  • Resveratrol inhibits ovarian cancer cell adhesion to peritoneal mesothelium in vitro by modulating the production of α5β1 integrins and hyaluronic acidPubmed:24995580
  • Establishing principles of macromolecular crowding for in vitro fibrosis research of the vocal fold lamina propriaPubmed:25545625
  • Pituitary tumor transforming gene as a novel regulatory factor of liver fibrosisPubMed: 25936962
  • Camel Milk: Potential Utility as an Adjunctive Therapy to Peg-IFN/RBV in HCV-5 Infected Patients in EgyptPubMed: 26492131
  • Study of Some Serum Biochemical Markers of Liver Fibrosis in Patients with Chronic HCVISSN 2575-7733
  • A putative Chondroprotective role for IL-1β and MPO in herbal treatment of experimental osteoarthritispubmed:29166937
  • Polycomb group proteins: Novel molecules associated with ultraviolet A-induced photoaging of human skin.pubmed:28962194
  • The effect of aerobic walking and lower body resistance exercise on serum COMP and hyaluronan, in both males and femalesPubmed:29536174
  • Evaluation of antifibrotic effects of coffee and cocoa extracts in rats with thioacetamide-induced fibrosis10.1007:s00217-018-3119-z
  • Juvenile Ovine Ex Vivo Larynges: Phonatory, Histologic, and Micro CT Based Anatomic Analyses
  • Selected elements of extracellular matrix of the skin in diabetes and insulin resistancePubmed: 31146169

Recommend products